Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Markets open

IDEXX Laboratories, Inc. Stock Price: Quote, Financials, Forecast & News (IDXX)

IDEXX Laboratories, Inc.

IDXX · Nasdaq

Overview Financials Earnings Holders Historical Data Analysis

Symbol: IDXX
Type: Stock
Sector: Health Care
Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
Country: North America
Exchange: Nasdaq

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions-to advance medical care, improve efficiency, and build thriving practices. Our innovations also help measure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.

Analyst Consensus

Buy

13 analysts

$593

Current

—

Low

$745

Average

—

High

Average target implies +25.68% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share ofTAK · NYSE$16.59

0.18%

argenx SE American Depositary SharesARGX · NASDAQ-GS$864.132.32%

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series ABRKRP · Nasdaq$390.872.82%

Regeneron Pharmaceuticals, Inc.REGN · NASDAQ-GS$770.361.28%

$592.76+$4.030.69%

As of: Aug 5, 2:37 PM

Prev Close: $588.09
Market Cap: $46.76B
Open: —
Trailing P/E: —
Day Range: $604.14 - $582.59
52W Range: $769.98 - $518.55
Forward P/E: —
EPS: —
Volume: 130.77K
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market

Zacks · 1d ago

Idexx (IDXX) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks · 1d ago

IDEXX Laboratories Q2 26 Earnings Conference Call At 8:30 AM ET

RTTNews · 1d ago

Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates

Zacks · 1d ago

IDEXX Labs Reports Higher Q2 Profit On Strong Revenue Growth; Lifts FY Earnings Outlook; Stock Up

RTTNews · 1d ago Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics

Zacks · 5d ago Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings

Zacks · Jul 27 Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth?

Zacks · Jul 22

Beta

—

Avg Volume

660.08K